Cutaneous analgesia before transradial access for coronary intervention to prevent radial artery spasm

Basit Öğe Kaydı
dc.authoridVural, Mustafa Gökhan/0000-0002-7055-0492
dc.authorwosidtokatli, alptug/AAD-3188-2019
dc.authorwosidGunduz, Huseyin/B-2279-2017
dc.authorwosidyilmaztepe, mustafa/AGE-8367-2022
dc.authorwosidVural, Mustafa Gökhan/JEO-5899-2023
dc.contributor.authorTatli, Ersan
dc.contributor.authorYilmaztepe, Mustafa Adem
dc.contributor.authorVural, Mustafa Gokhan
dc.contributor.authorTokatli, Alptug
dc.contributor.authorAksoy, Murat
dc.contributor.authorAgac, Mustafa Tarik
dc.contributor.authorCakar, Mehmet Akif
dc.date.accessioned2024-06-12T11:16:36Z
dc.date.available2024-06-12T11:16:36Z
dc.date.issued2018
dc.departmentTrakya Üniversitesien_US
dc.description.abstractAim: Transradial access (TRA) for coronary intervention is increasingly used in current clinical practice. The aim of the present study was to evaluate the hypothesis that cutaneous analgesia before TRA for coronary intervention at a puncture site 30 minutes before puncture can reduce patient discomfort and the incidence of radial artery spasm (RAS). Methods: Patients (n=104) undergoing planned coronary interventions using TRA were prospectively randomized to receive either 1 mL of 1% lidocaine subcutaneously (n=52) (control group) or subcutaneous lidocaine plus 5% lidocaine cream (n=52) cutaneously 30 minutes before puncture (treatment group). The primary endpoint was angiographically or clinically confirmed RAS. Secondary endpoints were the occurrence of patient discomfort in the forearm during the procedure and access-site crossover to the femoral artery. Patient discomfort was quantified with a visual analogue scale (VAS) score. Results: Fifty-two patients in the treatment group (60.5 +/- 9.4 years of age and 16 female) and 52 patients in the control group (60.4 +/- 9.7 years of age and 16 female) were included in the final analysis. Radial artery spasm occurrence decreased in the treatment group compared to the control group (26.9% vs 9.6%; p=0.04) accompanied by a VAS score of 3.7 +/- 1.8 in the treatment group and 4.9 +/- 2.0 in the control group; p=0.02. The access site crossover rate did not differ between the groups (7.6% vs 21.1%; p=0.09). Conclusion: Cutaneous analgesia before TRA for coronary interventions is associated with a substantial reduction in the RAS and the procedure-related level of patient discomfort.en_US
dc.identifier.doi10.1177/0267659117727823
dc.identifier.endpage114en_US
dc.identifier.issn0267-6591
dc.identifier.issn1477-111X
dc.identifier.issue2en_US
dc.identifier.pmid28825352en_US
dc.identifier.scopus2-s2.0-85041903642en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage110en_US
dc.identifier.urihttps://doi.org/10.1177/0267659117727823
dc.identifier.urihttps://hdl.handle.net/20.500.14551/24385
dc.identifier.volume33en_US
dc.identifier.wosWOS:000429463000005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSage Publications Ltden_US
dc.relation.ispartofPerfusion-Uken_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectTransradial Approachen_US
dc.subjectRadial Artery Spasmen_US
dc.subjectVisual Analogue Scaleen_US
dc.subjectTopical Lidocaineen_US
dc.subjectCardiac-Catheterizationen_US
dc.subjectProcedural Sedationen_US
dc.subjectVasodilatorsen_US
dc.subjectInfiltrationen_US
dc.subjectCannulationen_US
dc.subjectCocktailen_US
dc.titleCutaneous analgesia before transradial access for coronary intervention to prevent radial artery spasmen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu